Literature DB >> 22496564

Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals.

Frédéric Cassé1, Isabelle Bardou, Lydia Danglot, Aurélien Briens, Axel Montagne, Jérôme Parcq, Anuradha Alahari, Thierry Galli, Denis Vivien, Fabian Docagne.   

Abstract

Tissue-type plasminogen activator (tPA) regulates physiological processes in the brain, such as learning and memory, and plays a critical role in neuronal survival and neuroinflammation in pathological conditions. Here we demonstrate, by combining mouse in vitro and in vivo data, that tPA is an important element of the cross talk between neurons and astrocytes. The data show that tPA released by neurons is constitutively endocytosed by astrocytes via the low-density lipoprotein-related protein receptor, and is then exocytosed in a regulated manner. The exocytotic recycling of tPA by astrocytes is inhibited in the presence of extracellular glutamate. Kainate receptors of astrocytes act as sensors of extracellular glutamate and, via a signaling pathway involving protein kinase C, modulate the exocytosis of tPA. Further, by thus capturing extracellular tPA, astrocytes serve to reduce NMDA-mediated responses potentiated by tPA. Overall, this work provides the first demonstration that the neuromodulator, tPA, may also be considered as a gliotransmitter.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496564      PMCID: PMC6622090          DOI: 10.1523/JNEUROSCI.5296-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Traumatic brain injury: tissue-type plasminogen activator--harmful or beneficial?

Authors:  Denis Vivien; Carine Ali
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

2.  Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.

Authors:  Shravan K Chintala
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

3.  Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.

Authors:  Gerald Ponath; Sriram Ramanan; Mayyan Mubarak; William Housley; Seunghoon Lee; F Rezan Sahinkaya; Alexander Vortmeyer; Cedric S Raine; David Pitt
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

4.  Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice.

Authors:  René A Girard; Prashant S Chauhan; Torry A Tucker; Tim Allen; Jaswinder Kaur; Ann Jeffers; Kathleen Koenig; Galina Florova; Andrey A Komissarov; Tatiana A Gaidenko; Mignote B Chamiso; James Fowler; Danna E Morris; Krishna Sarva; Karan P Singh; Steven Idell; Richard D Idell
Journal:  Exp Brain Res       Date:  2019-11-16       Impact factor: 1.972

Review 5.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

6.  PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models.

Authors:  Fabian Docagne; Isabelle Bardou; Héloïse Lebas; Sylvaine Guérit; Audrey Picot; Anne Cécile Boulay; Antoine Fournier; Denis Vivien; Martine Cohen Salmon
Journal:  Cell Mol Life Sci       Date:  2022-05-28       Impact factor: 9.261

7.  Tissue plasminogen activator contributes to alterations of neuronal migration and activity-dependent responses in fragile X mice.

Authors:  V Swaroop Achuta; Veronika Rezov; Marko Uutela; Verna Louhivuori; Lauri Louhivuori; Maija L Castrén
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 8.  Gliocrine System: Astroglia as Secretory Cells of the CNS.

Authors:  Nina Vardjan; Vladimir Parpura; Alexei Verkhratsky; Robert Zorec
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  The Plasminogen Activation System Promotes Dendritic Spine Recovery and Improvement in Neurological Function After an Ischemic Stroke.

Authors:  Valerie Jeanneret; Manuel Yepes
Journal:  Transl Stroke Res       Date:  2016-02-04       Impact factor: 6.829

Review 10.  Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.

Authors:  Manuel Yepes; Yena Woo; Cynthia Martin-Jimenez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.